Atmosphere-ph.ru

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru

ИНТЕРНЕТ-МАГАЗИН

Лечебное дело
2021 / N 4

Красный плоский лишай: современные аспекты этиологии и патогенеза (обзор)
М.М. Тлиш, П.С. Осмоловская

Список литературы

1. Кубанов А.А., Перламутров Ю.Н., Олисова О.Ю., Чикин В.В., Минеева А.А., Ольховская К.Б. Федеральные клинические рекомендации. Российское общество дерматовенерологов и косметологов 2020. Доступно по: https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020/ Ссылка активна на 02.02.2022.
2. Georgescu SR, Tampa M, Mitran MI, Mitran CI, Sarbu MI, Nicolae I, Matei C, Caruntu C, Neagu M, Popa MI, Popa MI. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection. Experimental and Therapeutic Medicine 2019 Feb;17(2):1045-51.
3. Rekha SM, Annigeri AB, Galgali SR, Jagadish P. Multivariant lichen planus of lips and gingiva: report of a case and a review. International Journal of Oral Health Sciences & Advances 2018;8(2):109-15.
4. Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. The Scientific World Journal 2014 Jan;2014:742826.
5. Mendiratta V, Sanke S. Lichen planus. In: Harper’s textbook of pediatric dermatology. Hoeger P, Kinsler V, Yan A, Harper J, Oranje A, Bodemer C, Larralde M, Luk D, Mendiratta V, Purvis D, editors. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2019: 390-402.
6. DeAngelis LM, Cirillo N, McCullough MJ. The immunopathogenesis of oral lichen planus. Is there a role for mucosal associated invariant T cells? Journal of Oral Pathology and Medicine 2019 Aug;48(7):552-9.
7. Ioannides D, Vakirlis E, Kemeny L, Marinovic B, Massone C, Murphy R, Nast A, Ronnevig J, Ruzicka T, Cooper SM, Trüeb RM, Pujol Vallverdú RM, Wolf R, Neumann M. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology and Venereology 2020 Jul;34(7):1403-14.
8. Li C, Tang X, Zheng X, Ge S, Wen H, Lin X, Chen Z, Lu L. Global prevalence and incidence estimates of oral lichen planus: a systematic review and meta-analysis. JAMA Dermatology 2020 Feb;156(2):172-81.
9. Cholewa K, Mitas K, Zaremba B, Artykiewicz K, Kozyra M, Milanowska J. Current review of connections between lichen planus and mental disorders. Journal of Education, Health and Sport 2020 Mar;10(3):57-65.
10. Чуйкин С.В., Акмалова Г.М., Мирсаяпова И.А., Ронь Г.И., Чернышева Н.Д., Хайруллина Р.М. Особенности иммунного статуса у больных с разными клиническими формами красного плоского лишая слизистой оболочки рта. Инфекция и иммунитет 2019;9(1):128-34.
11. Aghamajidi A, Raoufi E, Parsamanesh G, Jalili A, Salehi-Shadkami M, Mehrali M, Mohsenzadegan M. The attentive focus on T cell-mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo. Journal of Immunology 2021 Apr;93(4):e13000.
12. Kurago Z B. Etiology and pathogenesis of oral lichen planus: an overview. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2016 Jul;122(1):72-80.
13. Rauschenberger T, Schmitt V, Azeem M, Klein-Hessling S, Murti K, Grän F, Goebeler M, Andreas Kerstan A, Klein M, Bopp T, Serfling E, Muhammad K. T cells control chemokine secretion by keratinocytes. Frontiers in Immunology 2019 Aug;10:1917.
14. Marshall A, Celentano A, Cirillo N, McCullough M, Porter S. Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: implications for oral inflammatorydisease. PLoS One 2017 Mar;12(3):0172821.
15. Carbone T, Nasorri F, Pennino D, Donnarumma M, Garcovich S, Eyerich K, Bergamo F, Cavani A. CD56highCD16- NK cell involvement in cutaneous lichen planus. European Journal of Dermatology 2010 Nov-Dec;20(6):724-30.
16. Clark RA, Schlapbach C. TH9 cells in skin disorders. Seminars in Immunopathology 2017 Jan;39(1):47-54.
17. Wang H, Bai J, Luo Z, Fu J, Wang H, Sun Z. Overexpression and varied clinical significance of Th9 versus Th17 cells in distinct subtypes of oral lichen planus. Archives of Oral Biology 2017 Aug;80:110-6.
18. Wang H, Guan X, Luo Z, Liu Y, Ren Q, Zhao X. The association and potentially destructive role of Th9/ИЛ-9 is synergistic with Th17 cells by elevating MMP9 production in local lesions of oral lichen planus. Journal of Oral Pathology & Medicine 2018 Apr;47(4):425-33.
19. Javvadi LR, Parachuru VP, Milne TJ, Seymour GJ, Rich AM. Regulatory T-cells and IL17A+ cells infiltrate oral lichen planus lesions. Pathology 2016 Oct;48(6):564-73.
20. Gueiros LA, Arão T, Souza T, Vieira CL, Gomez RS, Almeida OP, Lodi G, Leão JC. IL 17A polymorphism and elevated IL 17A serum levels are associated with oral lichen planus. Oral Diseases 2018 Apr;24(3):377-83.
21. Żychowska M, Batycka-Baran A, Baran W. Increased serum level and high tissue immunoexpression of interleukin 17 in cutaneous lichen planus: a novel therapeutic target for recalcitrant cases? Disease Markers 2020 Jul;2020:6521274.
22. Ismail FF, Sinclair R. Clinical healing of erosive oral lichen planus with tildrakizumab implicates the interleukin-23/interleukin-17 pathway in the pathogenesis of lichen planus. The Australasian Journal of Dermatology 2020 May;61(2):e244-5.
23. Knisley RR, Petropolis AA, Mackey VT. Lichen planus pemphigoides treated with ustekinumab. Cutis 2017 Dec;100(6):415-8.
24. Solimani F, Pollmann R, Schmidt T, Schmidt A, Zheng X, Savai R, Mühlenbein S, Pickert J, Eubel V, Möbs C, Eming R, Hertl M. Therapeutic targeting of Th17/Tc17 cells leads to clinical improvement of lichen planus. Frontiers in Immunology 2019 Jul;10:1808.
25. Lu R, Zeng X, Han Q, Lin M, Long L, Dan H, Zhou G, Chen Q. Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus. Mediators of Inflammation 2014;2014:701094.
26. Piccinni MP, Lombardelli L, Logiodice F, Tesi D, Kullolli O, Biagiotti R, Giudizi MG, Romagnani S, Maggi E. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Diseases 2014 Mar;20(2):212-8.
27. Pietschke K, Holstein J, Meier K, Schäfer I, Müller-Hermelink E, Gonzalez-Menendez I, Quintanilla-Martinez L, Ghoreschi FC, Solimani F, Ghoreschi K. The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition. Experimental Dermatology 2021 Feb;30(2):262-70.
28. Tian Y, Zajac AJ. IL-21 and T cell differentiation: consider the context. Trends in Immunolody 2016 Aug;37(8):557-68.
29. Strengell M, Matikainen S, Siren J, Lehtonen A, Foster D, Julkunen I, Sareneva T. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. Journal of Immunology (Baltimore, Md.: 1950) 2003 Jun;170(11):5464-9.
30. Alves de Medeiros AK, Speeckaert R, Desmet E, Van Gele M, De Schepper S, Lambert J. JAK3 as an emerging target for topical treatment of inflammatory skin diseases. PLoS One 2016 Oct;11(10):e0164080.
31. Damsky W, Wang A, Olamiju B, Peterson D, Galan A, King B. Treatment of severe lichen planus with the JAK inhibitor tofacitinib. The Journal of Allergy and Clinical Immunology 2020 Jun;145(6):1708-10.e2.
32. Yang CC, Khanna T, Sallee B, Christiano AM, Bordone LA. Tofacitinib for the treatment of lichen planopilaris: a case series. Dermatologic Therapy 2018 Nov;31(6):e12656.
33. Singal A. Familial mucosal lichen planus in three successive generations. International Journal of Dermatology 2005 Jan;44(1):81-2.
34. Gibstine CF, Esterly NB. Lichen planus in monozygotic twins. Archives of Dermatology 1984 May;120(5):580.
35. Guarneri F, Giuffrida R, Di Bari F, Cannavò SP, Benvenga S. Thyroid autoimmunity and lichen. Frontiers in Endocrinology 2017 Jun;8:146.
36. Голдсмит Л.А., Кац С.И., Джилкрест Б.А., Паллер Э.С., Леффель Д.Дж., Волф К. Пер. с англ., под общ. ред. Потекаева Н.Н., Львова А.Н. Изд. 2-е, испр. Дерматология Фицпатрика в клинической практике. В 3 т. Т. 1. М.: Издательство Панфилова; 2015. 1168 с.
37. Manolache L, Seceleanu-Petrescu D, Benea V. Lichen planus patients and stressful events. Journal of the European Academy of Dermatology and Venereology 2007 Apr;22(4):437-41.
38. Krasowska D, Pietrzak A, Surdacka A, Tuszyńska-Bogucka V, Janowski K, Roliński J. Psychological stress, endocrine and immune response in patients with lichen planus. International Journal of Dermatology 2008 Nov;47(11);1126-34.
39. Subhash S, Bindu RS, Nair PS. George AE. A study of serum cortisol levels in patients with lichen planus. Journal of Skin and Sexually Transmitted Diseases 2021 Feb;1-6.
40. Pokupec JS, Gruden V, Gruden V Jr. Lichen ruber planus as a psychiatric problem. Psychiatria Danubina 2009 Dec;21(4):514-6.
41. Torre K, Grant-Kels JM, Oliviero M, Rabinovitz H. Lichen planus eruption following annual influenza vaccination. JAAD Case Reports 2021 Mar;10:116-8.
42. Krupaa RJ, Sankari SL, Masthan KM, Rajesh E. Oral lichen planus: an overview. Journal of Pharmacy & Bioallied Sciences 2015 Apr;7(Suppl 1):S158-61.
43. Giudice A, Liborio F, Averta F, Barone S, Fortunato L. Oral lichenoid reaction: an uncommon side effect of rituximab. Case Reports in Dentistry 2019 Nov;2019:3154856.
44. Rosengard HC, Wheat CM, Tilson MP, Cuda JD. Lichen planus following tetanus-diphtheria-acellular pertussis vaccination: a case report and review of the literature. SAGE Open Medical Case Reports 2018 Jan;6:2050313X17750335.
45. An I, Demir V, İbiloğlu İ, Akdeniz S. Lichen planus secondary to rabies vaccination. Dermatology Online Journal 2017 Mar 15;23(3):13030/qt3hr3t4hs.
46. Kluger N. Radiation-associated lichen planus: a case report and literature review. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 2017 Dec;26(4):105-8.
47. Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P. Lichen planus and hepatitis C virus. Journal of the American Academy of Dermatology 1991 May;24(5 Pt 1):792.
48. Lodi G, Pellicano RR, Carrozzo M. Review hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Diseases 2010;16(7):601-12.
49. Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011 Jul;99(2):168-78.
50. Carrozzo M, Brancatello F, Dametto E, Arduino P, Pentenero M, Rendine S, Porter SR, Lodi G, Scully C, Gandolfo S. Hepatitis C virus-associated oral lichen planus: is the geographical heterogeneity related to HLA-DR6? Journal of Oral Pathology and Medicine 2005 Apr;34(4):204-8.
51. Femiano F, Scully C. Functions of the cytokines in relation oral lichen planus-hepatitis C. Medicina Oral, Patologia Oral y Cirugia Bucal 2005 Apr;10(Suppl 1):E40-4.
52. Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F, Carrozzo M, Mori C, Giuberti T, Ferrari C, Missale G. Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology (Baltimore, Md.) 2002 Dec;36(6):1446-52.
53. Zhou Y, Jiang L, Liu J, Zeng X, Chen QM. The prevalence of hepatitis C virus infection in oral lichen planus in an ethnic Chinese cohort of 232 patients. International Journal of Oral Science 2010 Jun;2(2):90-7.
54. Song J, Zhang Z, Ji X, Su S, Liu X, Xu S, Han Y, Mu D, Liu H. Lack of evidence of hepatitis in patients with oral lichen planus in China: a case control study. Medicina Oral, Patologia Oral y Cirugia Bucal 2016 Mar;21(2):e161-8.
55. Żychowska M, Żychowska M. No evidence for association between cutaneous lichen planus and hepatitis B and C virus infection in south Poland – a case-control study. International Journal of Dermatology 2020 Jun;59(6):698-703.
56. Shengyuan L, Songpo Y, Wen W, Wenjing T, Haitao Z, Binyou W. Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Archives of Dermatology 2009 Sep;145(9):1040-7.
57. el-Kabir M, Scully C, Porter S, Porter K, Macnamara E. Liver function in UK patients with oral lichen planus. Clinical and Experimental Dermatology 1993 Jan;18:12-6.
58. Tanei R, Watanabe K, Nishiyama S. Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C. The Journal of Dermatology1995 May;22(5):316-23.
59. Garcovich S, Garcovich M, Capizzi R, Gasbarrini A, Zocco MA. Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World Journal of Hepatology 2015 Nov;7(27):2740-8.
60. Maitland NJ, Cox MF, Lynas C, Prime SS, Meanwell CA, Scully C. Detection of human papillomavirus DNA in biopsies of human oral tissue. British Journal of Cancer 1987 Sep;56(3):245-50.
61. Giovannelli L, Campisi G, Colella G, Capra G, Di Liberto C, Caleca MP, Matranga D, D’Angelo M, Muzio LL, Ammatuna P. Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions. Molecular Diagnosis and Therapy 2006;10(1):49-55.
62. Ma J, Zhang J, Zhang Y, Lv T, Liu J. The magnitude of the association between human papillomavirus and oral lichen planus: a meta-analysis. PLoS One 2016 Aug;11(8):e0161339.
63. Gorsky M, Epstein JB. Oral lichen planus: malignant transformation and human papilloma virus: a review of potential clinical implications. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology 2011;111:461-4.
64. Razavi SM, Ghalayani P, Salehi MR, Attarzadeh H, Shahmoradi M. Human papilloma virus as a possible factor in the pathogenesis of oral lichen planus. Dental Research Journal 2009;6(2):82-6.
65. Mattila R, Rautava J, Syrjänen S. Human papillomavirus in oral atrophic lichen planus lesions. Oral Oncology 2012 Oct;48(10):980-4.
66. Sahebjamiee M, Sand L, Karimi S, Biettolahi JM, Jabalameli F, Jalouli J. Prevalence of human papillomavirus in oral lichen planus in an Iranian cohort. Journal of Oral and Maxillofacial Pathology 2015 May-Aug;19(2):170-4.
67. Lundström IM. Incidence of diabetes mellitus in patients with oral lichen planus. International Journal of Oral Surgery1983 Jun;12(3):147-52.
68. Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital university Saints Malaysia. The Malaysian Journal of Medical Sciences 2013;20(4):39-46.
69. Nosratzehi T, Arbabi-Kalati F, Arefpour Z. Lack of association between diabetes mellitus and oral lichen planus in Zahedan (South-East of Iran). Caspian Journal of Dental Research 2015;4:8-12.
70. De Souza Bastos A, Leite ARP, Spin-Neto R, Nassar PO, Massucato EMS, Orrico SRP. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Research and Clinical Practice 2011Apr;92(1):100-5.
71. Van Dis ML, Parks ET. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 1995 Jun;79(6):696-700.
72. Mozaffari HR, Sharifi R, Sadeghi M. Prevalence of oral lichen planus in diabetes mellitus: a meta-analysis study. Acta Informatica Medica 2016 Dec;24(6):390-3.
73. Bagewadi A, Bhoweer AK. Oral lichen planus and its association with diabetes mellitus and hypertension. Journal of Indian Academy Oral Medicine and Radiology 2011;23(5):300-3.
74. López-Jornet P, Parra-Perez F, Pons-Fuster A. Association of autoimmune diseases with oral lichen planus: a cross-sectional, clinical study. Journal of the European Academy of Dermatology and Venereology 2014 Jul;28(7):895-9.
75. Krishnamoorthy B, Suma GN, Mamatha NS, Sowbhagya MB, Garlapati K. Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India – a descriptive study. Journal of Clinical and Diagnostic Research 2014 Nov;8(11):ZC92-5.
76. Yusuf SM, Tiijani UA, Maiyaki MB, Nashabaru I, Uloko AE, Gezaqa ID. Dyslipidemia: prevalence and associated risk factors among patients with lichen planus in Kano, North-West Nigeria. Nigerian Quarterly Journal of Hospital Medicine 2015 Jul-Sep;25(3):145-50.
77. Panchal FH, Ray S, Munshi RP, Bhalerao SS, Nayak CS. Alterations in lipid metabolism and antioxidant status in lichen planus. Indian Journal of Dermatology 2015 Sep-Oct;60(5):439-44.
78. Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, Girón-Prieto MS, Gutiérrez-Salmerón MT, Mellado VG, Cutando A, Naranjo-Sintes R. Cardiovascular risk factors in patients with lichen planus. The American Journal of Medicine 2011 Jun;124(6):543-8.
79. Okpala IC, Akinboro AO, Ezejoifor IO, Onunu AN, Okwara BU. Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: a cross-sectional study. Indian Journal of Dermatology 2019 Jul-Aug;64(4):303-10.
80. Hashba H, Bifi J, Thyvalappil A, Sridharan R, Sreenivasan A, Mathew P. Prevalence of metabolic syndrome in patients with lichen planus: a cross-sectional study from a tertiary care center. Indian Dermatology Online Journal 2018 Sep-Oct;9(5):304-8.
81. Baykal L, Arica DA, Yayli S, Orem A, Bahadir S, Altun E, Yaman H. Prevalence of metabolic syndrome in patients with mucosal lichen planus: a case-control study. American Journal of Clinical Dermatology 2015 Oct;16(5):439-45.
82. Ying J, Xiang W, Qiu Y, Zeng X. Risk of metabolic syndrome in patients with lichen planus: a systematic review and meta-analysis. PLoS One 2020 Aug;15(8):e0238005.
83. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 Dec;37(12):1595-607.
84. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. The Journal of Clinical Endocrinology and Metabolism 2008 Nov;93(11 Suppl 1):64-73.
85. Sadr Eshkevari S, Aghazadeh N, Saedpanah R, Mohammadhosseini M, Karimi S, Nikkhah N. The association of cutaneous lichen planus and metabolic syndrome: a case-control study. Journal Skin and Stem Cell 2016 Dec;3(4):66785.
86. Saleh N, Samir N, Megahed H, Farid E. Homocysteine and other cardiovascular risk factors in patients with lichen planus. Journal of the European Academy of Dermatology and Venereology 2014 Nov;28(11):1507-13.
87. Daye M, Aykut Temiz S, Isık B. The relationship between lichen planus and metabolic syndrome. Journal of Cosmetic Dermatology 2021 Aug;20(8):2635-9.
88. Sharma A, Khare AK, Gupta LK, Mittal A, Mehta S, Balai M. A clinic-epidemiological study of patients with lichen planus and associated metabolic complications at a tertiary care centre. Our Dermatology Online 2021;12:6.

References

1. Kubanov AA, Perlamutrov YuN, Olisova OYu, Chikin VV, Mineyeva AA, Olkhovskaya KB. Federal clinical guidelines. Russian Society of Dermatovenerologists and Cosmetologists 2020. Available from: https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020 / Accessed 2022 Feb 02. (In Russian).
2. Georgescu SR, Tampa M, Mitran MI, Mitran CI, Sarbu MI, Nicolae I, Matei C, Caruntu C, Neagu M, Popa MI, Popa MI. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection. Experimental and Therapeutic Medicine 2019 Feb;17(2):1045-51.
3. Rekha SM, Annigeri AB, Galgali SR, Jagadish P. Multivariant lichen planus of lips and gingiva: report of a case and a review. International Journal of Oral Health Sciences & Advances 2018;8(2):109-15.
4. Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. The Scientific World Journal 2014 Jan;2014:742826.
5. Mendiratta V, Sanke S. Lichen planus. In: Harper’s textbook of pediatric dermatology. Hoeger P, Kinsler V, Yan A, Harper J, Oranje A, Bodemer C, Larralde M, Luk D, Mendiratta V, Purvis D, editors. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2019: 390-402.
6. DeAngelis LM, Cirillo N, McCullough MJ. The immunopathogenesis of oral lichen planus. Is there a role for mucosal associated invariant T cells? Journal of Oral Pathology and Medicine 2019 Aug;48(7):552-9.
7. Ioannides D, Vakirlis E, Kemeny L, Marinovic B, Massone C, Murphy R, Nast A, Ronnevig J, Ruzicka T, Cooper SM, Trüeb RM, Pujol Vallverdú RM, Wolf R, Neumann M. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology and Venereology 2020 Jul;34(7):1403-14.
8. Li C, Tang X, Zheng X, Ge S, Wen H, Lin X, Chen Z, Lu L. Global prevalence and incidence estimates of oral lichen planus: a systematic review and meta-analysis. JAMA Dermatology 2020 Feb;156(2):172-81.
9. Cholewa K, Mitas K, Zaremba B, Artykiewicz K, Kozyra M, Milanowska J. Current review of connections between lichen planus and mental disorders. Journal of Education, Health and Sport 2020 Mar;10(3):57-65.
10. Chuykin SV, Akmalova GM, Mirsayapova IA, Ron GI, Chernysheva ND, Khayrullina RM. Features of immune status in patients with various clinical forms of oral lichen planus. Infection and Immunity 2019;9(1):128-34 (In Russian).
11. Aghamajidi A, Raoufi E, Parsamanesh G, Jalili A, Salehi-Shadkami M, Mehrali M, Mohsenzadegan M. The attentive focus on T cell-mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo. Journal of Immunology 2021 Apr;93(4):e13000.
12. Kurago Z B. Etiology and pathogenesis of oral lichen planus: an overview. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2016 Jul;122(1):72-80.
13. Rauschenberger T, Schmitt V, Azeem M, Klein-Hessling S, Murti K, Grän F, Goebeler M, Andreas Kerstan A, Klein M, Bopp T, Serfling E, Muhammad K. T cells control chemokine secretion by keratinocytes. Frontiers in Immunology 2019 Aug;10:1917.
14. Marshall A, Celentano A, Cirillo N, McCullough M, Porter S. Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: implications for oral inflammatorydisease. PLoS One 2017 Mar;12(3):0172821.
15. Carbone T, Nasorri F, Pennino D, Donnarumma M, Garcovich S, Eyerich K, Bergamo F, Cavani A. CD56highCD16- NK cell involvement in cutaneous lichen planus. European Journal of Dermatology 2010 Nov-Dec;20(6):724-30.
16. Clark RA, Schlapbach C. TH9 cells in skin disorders. Seminars in Immunopathology 2017 Jan;39(1):47-54.
17. Wang H, Bai J, Luo Z, Fu J, Wang H, Sun Z. Overexpression and varied clinical significance of Th9 versus Th17 cells in distinct subtypes of oral lichen planus. Archives of Oral Biology 2017 Aug;80:110-6.
18. Wang H, Guan X, Luo Z, Liu Y, Ren Q, Zhao X. The association and potentially destructive role of Th9/ИЛ-9 is synergistic with Th17 cells by elevating MMP9 production in local lesions of oral lichen planus. Journal of Oral Pathology & Medicine 2018 Apr;47(4):425-33.
19. Javvadi LR, Parachuru VP, Milne TJ, Seymour GJ, Rich AM. Regulatory T-cells and IL17A+ cells infiltrate oral lichen planus lesions. Pathology 2016 Oct;48(6):564-73.
20. Gueiros LA, Arão T, Souza T, Vieira CL, Gomez RS, Almeida OP, Lodi G, Leão JC. IL 17A polymorphism and elevated IL 17A serum levels are associated with oral lichen planus. Oral Diseases 2018 Apr;24(3):377-83.
21. Żychowska M, Batycka-Baran A, Baran W. Increased serum level and high tissue immunoexpression of interleukin 17 in cutaneous lichen planus: a novel therapeutic target for recalcitrant cases? Disease Markers 2020 Jul;2020:6521274.
22. Ismail FF, Sinclair R. Clinical healing of erosive oral lichen planus with tildrakizumab implicates the interleukin-23/interleukin-17 pathway in the pathogenesis of lichen planus. The Australasian Journal of Dermatology 2020 May;61(2):e244-5.
23. Knisley RR, Petropolis AA, Mackey VT. Lichen planus pemphigoides treated with ustekinumab. Cutis 2017 Dec;100(6):415-8.
24. Solimani F, Pollmann R, Schmidt T, Schmidt A, Zheng X, Savai R, Mühlenbein S, Pickert J, Eubel V, Möbs C, Eming R, Hertl M. Therapeutic targeting of Th17/Tc17 cells leads to clinical improvement of lichen planus. Frontiers in Immunology 2019 Jul;10:1808.
25. Lu R, Zeng X, Han Q, Lin M, Long L, Dan H, Zhou G, Chen Q. Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus. Mediators of Inflammation 2014;2014:701094.
26. Piccinni MP, Lombardelli L, Logiodice F, Tesi D, Kullolli O, Biagiotti R, Giudizi MG, Romagnani S, Maggi E. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Diseases 2014 Mar;20(2):212-8.
27. Pietschke K, Holstein J, Meier K, Schäfer I, Müller-Hermelink E, Gonzalez-Menendez I, Quintanilla-Martinez L, Ghoreschi FC, Solimani F, Ghoreschi K. The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition. Experimental Dermatology 2021 Feb;30(2):262-70.
28. Tian Y, Zajac AJ. IL-21 and T cell differentiation: consider the context. Trends in Immunolody 2016 Aug;37(8):557-68.
29. Strengell M, Matikainen S, Siren J, Lehtonen A, Foster D, Julkunen I, Sareneva T. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. Journal of Immunology (Baltimore, Md.: 1950) 2003 Jun;170(11):5464-9.
30. Alves de Medeiros AK, Speeckaert R, Desmet E, Van Gele M, De Schepper S, Lambert J. JAK3 as an emerging target for topical treatment of inflammatory skin diseases. PLoS One 2016 Oct;11(10):e0164080.
31. Damsky W, Wang A, Olamiju B, Peterson D, Galan A, King B. Treatment of severe lichen planus with the JAK inhibitor tofacitinib. The Journal of Allergy and Clinical Immunology 2020 Jun;145(6):1708-10.e2.
32. Yang CC, Khanna T, Sallee B, Christiano AM, Bordone LA. Tofacitinib for the treatment of lichen planopilaris: a case series. Dermatologic Therapy 2018 Nov;31(6):e12656.
33. Singal A. Familial mucosal lichen planus in three successive generations. International Journal of Dermatology 2005 Jan;44(1):81-2.
34. Gibstine CF, Esterly NB. Lichen planus in monozygotic twins. Archives of Dermatology 1984 May;120(5):580.
35. Guarneri F, Giuffrida R, Di Bari F, Cannavò SP, Benvenga S. Thyroid autoimmunity and lichen. Frontiers in Endocrinology 2017 Jun;8:146.
36. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolf K. 2nd ed., revised. Fitzpatrick’s dermatology in General medicine. 3-vol. set. Vol. 1. Moscow: Izdatelstvo Panfilova; 2015. 1168 p. (In Russian).
37. Manolache L, Seceleanu-Petrescu D, Benea V. Lichen planus patients and stressful events. Journal of the European Academy of Dermatology and Venereology 2007 Apr;22(4):437-41.
38. Krasowska D, Pietrzak A, Surdacka A, Tuszyńska-Bogucka V, Janowski K, Roliński J. Psychological stress, endocrine and immune response in patients with lichen planus. International Journal of Dermatology 2008 Nov;47(11);1126-34.
39. Subhash S, Bindu RS, Nair PS. George AE. A study of serum cortisol levels in patients with lichen planus. Journal of Skin and Sexually Transmitted Diseases 2021 Feb;1-6.
40. Pokupec JS, Gruden V, Gruden V Jr. Lichen ruber planus as a psychiatric problem. Psychiatria Danubina 2009 Dec;21(4):514-6.
41. Torre K, Grant-Kels JM, Oliviero M, Rabinovitz H. Lichen planus eruption following annual influenza vaccination. JAAD Case Reports 2021 Mar;10:116-8.
42. Krupaa RJ, Sankari SL, Masthan KM, Rajesh E. Oral lichen planus: an overview. Journal of Pharmacy & Bioallied Sciences 2015 Apr;7(Suppl 1):S158-61.
43. Giudice A, Liborio F, Averta F, Barone S, Fortunato L. Oral lichenoid reaction: an uncommon side effect of rituximab. Case Reports in Dentistry 2019 Nov;2019:3154856.
44. Rosengard HC, Wheat CM, Tilson MP, Cuda JD. Lichen planus following tetanus-diphtheria-acellular pertussis vaccination: a case report and review of the literature. SAGE Open Medical Case Reports 2018 Jan;6:2050313X17750335.
45. An I, Demir V, İbiloğlu İ, Akdeniz S. Lichen planus secondary to rabies vaccination. Dermatology Online Journal 2017 Mar 15;23(3):13030/qt3hr3t4hs.
46. Kluger N. Radiation-associated lichen planus: a case report and literature review. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 2017 Dec;26(4):105-8.
47. Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P. Lichen planus and hepatitis C virus. Journal of the American Academy of Dermatology 1991 May;24(5 Pt 1):792.
48. Lodi G, Pellicano RR, Carrozzo M. Review hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Diseases 2010;16(7):601-12.
49. Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011 Jul;99(2):168-78.
50. Carrozzo M, Brancatello F, Dametto E, Arduino P, Pentenero M, Rendine S, Porter SR, Lodi G, Scully C, Gandolfo S. Hepatitis C virus-associated oral lichen planus: is the geographical heterogeneity related to HLA-DR6? Journal of Oral Pathology and Medicine 2005 Apr;34(4):204-8.
51. Femiano F, Scully C. Functions of the cytokines in relation oral lichen planus-hepatitis C. Medicina Oral, Patologia Oral y Cirugia Bucal 2005 Apr;10(Suppl 1):E40-4.
52. Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F, Carrozzo M, Mori C, Giuberti T, Ferrari C, Missale G. Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology (Baltimore, Md.) 2002 Dec;36(6):1446-52.
53. Zhou Y, Jiang L, Liu J, Zeng X, Chen QM. The prevalence of hepatitis C virus infection in oral lichen planus in an ethnic Chinese cohort of 232 patients. International Journal of Oral Science 2010 Jun;2(2):90-7.
54. Song J, Zhang Z, Ji X, Su S, Liu X, Xu S, Han Y, Mu D, Liu H. Lack of evidence of hepatitis in patients with oral lichen planus in China: a case control study. Medicina Oral, Patologia Oral y Cirugia Bucal 2016 Mar;21(2):e161-8.
55. Żychowska M, Żychowska M. No evidence for association between cutaneous lichen planus and hepatitis B and C virus infection in south Poland – a case-control study. International Journal of Dermatology 2020 Jun;59(6):698-703.
56. Shengyuan L, Songpo Y, Wen W, Wenjing T, Haitao Z, Binyou W. Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Archives of Dermatology 2009 Sep;145(9):1040-7.
57. el-Kabir M, Scully C, Porter S, Porter K, Macnamara E. Liver function in UK patients with oral lichen planus. Clinical and Experimental Dermatology 1993 Jan;18:12-6.
58. Tanei R, Watanabe K, Nishiyama S. Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C. The Journal of Dermatology1995 May;22(5):316-23.
59. Garcovich S, Garcovich M, Capizzi R, Gasbarrini A, Zocco MA. Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World Journal of Hepatology 2015 Nov;7(27):2740-8.
60. Maitland NJ, Cox MF, Lynas C, Prime SS, Meanwell CA, Scully C. Detection of human papillomavirus DNA in biopsies of human oral tissue. British Journal of Cancer 1987 Sep;56(3):245-50.
61. Giovannelli L, Campisi G, Colella G, Capra G, Di Liberto C, Caleca MP, Matranga D, D’Angelo M, Muzio LL, Ammatuna P. Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions. Molecular Diagnosis and Therapy 2006;10(1):49-55.
62. Ma J, Zhang J, Zhang Y, Lv T, Liu J. The magnitude of the association between human papillomavirus and oral lichen planus: a meta-analysis. PLoS One 2016 Aug 29;11(8):e0161339.
63. Gorsky M, Epstein JB. Oral lichen planus: malignant transformation and human papilloma virus: a review of potential clinical implications. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology 2011;111:461-4.
64. Razavi SM, Ghalayani P, Salehi MR, Attarzadeh H, Shahmoradi M. Human papilloma virus as a possible factor in the pathogenesis of oral lichen planus. Dental Research Journal 2009;6(2):82-6.
65. Mattila R, Rautava J, Syrjänen S. Human papillomavirus in oral atrophic lichen planus lesions. Oral Oncology 2012 Oct;48(10):980-4.
66. Sahebjamiee M, Sand L, Karimi S, Biettolahi JM, Jabalameli F, Jalouli J. Prevalence of human papillomavirus in oral lichen planus in an Iranian cohort. Journal of Oral and Maxillofacial Pathology 2015 May-Aug;19(2):170-4.
67. Lundström IM. Incidence of diabetes mellitus in patients with oral lichen planus. International Journal of Oral Surgery1983 Jun;12(3):147-52.
68. Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital university Saints Malaysia. The Malaysian Journal of Medical Sciences 2013;20(4):39-46.
69. Nosratzehi T, Arbabi-Kalati F, Arefpour Z. Lack of association between diabetes mellitus and oral lichen planus in Zahedan (South-East of Iran). Caspian Journal of Dental Research 2015;4:8-12.
70. De Souza Bastos A, Leite ARP, Spin-Neto R, Nassar PO, Massucato EMS, Orrico SRP. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Research and Clinical Practice 2011Apr;92(1):100-5.
71. Van Dis ML, Parks ET. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 1995 Jun;79(6):696-700.
72. Mozaffari HR, Sharifi R, Sadeghi M. Prevalence of oral lichen planus in diabetes mellitus: a meta-analysis study. Acta Informatica Medica 2016 Dec;24(6):390-3.
73. Bagewadi A, Bhoweer AK. Oral lichen planus and its association with diabetes mellitus and hypertension. Journal of Indian Academy Oral Medicine and Radiology 2011;23(5):300-3.
74. López-Jornet P, Parra-Perez F, Pons-Fuster A. Association of autoimmune diseases with oral lichen planus: a cross-sectional, clinical study. Journal of the European Academy of Dermatology and Venereology 2014 Jul;28(7):895-9.
75. Krishnamoorthy B, Suma GN, Mamatha NS, Sowbhagya MB, Garlapati K. Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India – a descriptive study. Journal of Clinical and Diagnostic Research 2014 Nov;8(11):ZC92-5.
76. Yusuf SM, Tiijani UA, Maiyaki MB, Nashabaru I, Uloko AE, Gezaqa ID. Dyslipidemia: prevalence and associated risk factors among patients with lichen planus in Kano, North-West Nigeria. Nigerian Quarterly Journal of Hospital Medicine 2015 Jul-Sep;25(3):145-50.
77. Panchal FH, Ray S, Munshi RP, Bhalerao SS, Nayak CS. Alterations in lipid metabolism and antioxidant status in lichen planus. Indian Journal of Dermatology 2015 Sep-Oct;60(5):439-44.
78. Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, Girón-Prieto MS, Gutiérrez-Salmerón MT, Mellado VG, Cutando A, Naranjo-Sintes R. Cardiovascular risk factors in patients with lichen planus. The American Journal of Medicine 2011 Jun;124(6):543-8.
79. Okpala IC, Akinboro AO, Ezejoifor IO, Onunu AN, Okwara BU. Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: a cross-sectional study. Indian Journal of Dermatology 2019 Jul-Aug;64(4):303-10.
80. Hashba H, Bifi J, Thyvalappil A, Sridharan R, Sreenivasan A, Mathew P. Prevalence of metabolic syndrome in patients with lichen planus: a cross-sectional study from a tertiary care center. Indian Dermatology Online Journal 2018 Sep-Oct;9(5):304-8.
81. Baykal L, Arica DA, Yayli S, Orem A, Bahadir S, Altun E, Yaman H. Prevalence of metabolic syndrome in patients with mucosal lichen planus: a case-control study. American Journal of Clinical Dermatology 2015 Oct;16(5):439-45.
82. Ying J, Xiang W, Qiu Y, Zeng X. Risk of metabolic syndrome in patients with lichen planus: a systematic review and meta-analysis. PLoS One 2020 Aug;15(8):e0238005.
83. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 Dec;37(12):1595-607.
84. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. The Journal of Clinical Endocrinology and Metabolism 2008 Nov;93(11 Suppl 1):64-73.
85. Sadr Eshkevari S, Aghazadeh N, Saedpanah R, Mohammadhosseini M, Karimi S, Nikkhah N. The association of cutaneous lichen planus and metabolic syndrome: a case-control study. Journal Skin and Stem Cell 2016 Dec;3(4):66785.
86. Saleh N, Samir N, Megahed H, Farid E. Homocysteine and other cardiovascular risk factors in patients with lichen planus. Journal of the European Academy of Dermatology and Venereology 2014 Nov;28(11):1507-13.
87. Daye M, Aykut Temiz S, Isık B. The relationship between lichen planus and metabolic syndrome. Journal of Cosmetic Dermatology 2021 Aug;20(8):2635-9.
88. Sharma A, Khare AK, Gupta LK, Mittal A, Mehta S, Balai M. A clinic-epidemiological study of patients with lichen planus and associated metabolic complications at a tertiary care centre. Our Dermatology Online 2021;12:6.

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]